Vijay Pande and Steph Smith discuss using DNA as data storage, comparing it to Moore's Law. They explore DNA's capacity, longevity, and potential for the future of biotech. The podcast covers advancements in DNA storage, challenges in DNA synthesis, and the efficiency of using DNA for data storage.

Join Julie Klapstein and Julie Yoo as they discuss the evolution of healthcare technology, challenges faced by providers and payers, and the role of AI in improving revenue cycle management and clinical decision support. Explore Julie Klapstein's journey in healthcare IT, from battling outdated systems to embracing network effects. Discover the potential of AI in automating tasks within EMR systems and enhancing efficiency in the healthcare industry.

Ben Oakes, Scribe Therapeutics cofounder and CEO, discusses his journey in genome editing, transforming bacterial immune systems into genome editing tools. They explore the challenges of engineering these molecules and the potential for life-changing therapeutics. Topics include the intersection of engineering and biology, advancements in gene editing for chronic conditions, and the role of luck in discoveries.

Josh Clemente, cofounder and president of Levels, discusses wearable tech for tracking biomarkers and the potential of AI in simplifying wearables data into actionable health profiles. He shares his journey from SpaceX to cofounding Levels and talks about the future of continuous health awareness. The podcast also explores the significance of continuous glucose monitoring, the limitations of glucose detecting sensors, and the potential applications of wearable device data in healthcare.

Former gymnast Aly Raisman discusses her transition to being an investor, her passion for financial literacy, and her appreciation for founders' work ethic. They also talk about mental health during their gymnastics career, the importance of therapy and nutrition, and the challenges in the healthcare system.

Eren Bali, founder and CEO of Carbon Health, and Max Cohen, cofounder and CEO of Sprinter Health, discuss their experiences transitioning from tech to healthcare, finding product-market fit, tracking KPIs, and adapting to changes in the investor landscape. They reflect on the complexity of the healthcare industry, the challenges of addressing individual needs, and the advantages and opportunities for tech companies in healthcare

Joe Grogan, senior fellow at the Leonard D. Schaeffer Center for Health Policy and Economics, discusses his experience during the early days of the COVID pandemic. He shares insights on the Inflation Reduction Act's impact on pharmaceutical R&D and the future of AI regulation.

Rahul Kakkar, John Finn, and Jorge Conde discuss PASTE, a genome editing technique that could make cell therapy more accessible. They explore advancements in genomic medicine, CRISPR technology, and focus on genetic diseases of the liver and autoimmune diseases. They also touch on challenges in transitioning from research to patients and share anecdotes about facial hair.

Vijay Pande, founding partner of Bio + Health, discusses the evolution of AI, the pioneers in the field, and the shift to biology. He highlights the advancements in biology, the challenges of obtaining data, and the importance of multiple perspectives in understanding cells. The podcast also explores the opportunities in AI startups and how AI is being integrated into life sciences and healthcare companies.

Sean Duffy, cofounder and CEO of Omada Health, joins Vijay Pande to discuss the building and growth of Omada, the future of AI in healthcare, and the challenges of using technology in a caregiving environment. They also reflect on their personal and professional development over the years and highlight innovative solutions to scaling healthcare.